Castle Biosciences, Inc. (CSTL)

Castle Biosciences Revenue

Castle Biosciences had revenue of $85.78M in the quarter ending September 30, 2024, with 39.50% growth. This brings the company's revenue in the last twelve months to $311.88M, up 62.43% year-over-year. In the year 2023, Castle Biosciences had annual revenue of $219.79M with 60.38% growth.

• Revenue (ttm): $311.88M
• Revenue Growth: +62.43%
• P/S Ratio: 2.51
• Revenue / Employee: $511,275
• Employees: 610
• Market Cap: 796.81M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	219.79M	82.75M	60.38%
Dec 31, 2022	137.04M	42.95M	45.65%
Dec 31, 2021	94.09M	31.44M	50.18%
Dec 31, 2020	62.65M	10.78M	20.79%
Dec 31, 2019	51.87M	29.08M	127.62%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.